Clinical trial

Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

NCT01517282

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-01-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2012-01-01Date precision: month

Registry last updated2014-11-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

MOR103BIOLOGICAL

PlaceboOTHER

Sponsors & collaborators

MorphoSys AGlead sponsor

Mapped research locations

BerlinGermany1 ManchesterUnited Kingdom1 PoznanPoland1 GdanskPoland1 NottinghamUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01517282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.